To promote the clinical theranostic performances of platinum‐based anticancer drugs,
imaging capability is urgently desired, and their chemotherapeutic efficacy needs to be …

Discrete Pt (II) metallacycles have attracted particular attention for the chemotherapeutic
treatment of cancer. However, a single chemotherapy cannot simultaneously balance …

Fluorescent theranostics probes at the second near-IR region (NIR-II; 1.0–1.7 µm) are in
high demand for precise theranostics that minimize autofluorescence, reduce photon …

The scarcity of efficient imaging technologies for precise cancer treatment greatly drives the
development of new nanotheranostic based platforms that enable both diagnostic and …

The development of metallacycles with high stability and intense near-infrared (NIR)
absorption is important for biomedical applications. However, very few molecular design …

Discrete Pt (II) metallacycles have potential applications in biomedicine. Herein, we
engineered a dual-modal imaging and chemo-photothermal therapeutic nano-agent 1 that …

Despite the well-known anticancer activity of mono-and multinuclear platinum complexes,
studies of the antitumor performances of platinum-based supramolecular coordination …

The covalent linkage of supramolecular monomers provides a powerful strategy for
constructing dynamic polymeric materials whose properties can be readily tuned either by …

A theranostic agent combines diagnostic reporter with therapeutic activity in a single entity,
an approach that seeks to increase the efficacy of cancer treatment. Herein, we describe the …

Multifunctional nanotheranostic agents have been highly commended due to the application
to image-guided cancer therapy. Herein, based on the chemically disordered face centered …